Sterling Capital Management
IART icon

Sterling Capital Management’s Integra LifeSciences IART Stock Holding History

Sterling Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.7K Sell
1,333
-47
-3% -$811 ﹤0.01% 2158
2026
Q2 		$24.8K Sell
1,380
-855
-38% -$12K ﹤0.01% 1791
2026
Q1 		$21.1K Sell
2,235
-1,650
-42% -$18.1K ﹤0.01% 2007
2025
Q4 		$48.3K Sell
3,885
-743
-16% -$9.9K ﹤0.01% 1816
2025
Q3 		$66.3K Buy
4,628
+2,815
+155% +$38.6K ﹤0.01% 1671
2025
Q2 		$22.2K Buy
1,813
+646
+55% +$9.38K ﹤0.01% 1755
2025
Q1 		$25.7K Sell
1,167
-999
-46% -$23.5K ﹤0.01% 1591
2024
Q4 		$49.1K Buy
2,166
+1,931
+822% +$42.1K ﹤0.01% 1615
2024
Q3 		$4.27K Buy
+235
New +$5.45K ﹤0.01% 1823

Other funds holding IART

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Access Investment Management
Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Leeward Investments
Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Sterling Capital Management's IART Position: Q3 2026 in Review

Sterling Capital Management reduced its Integra LifeSciences (IART) stake by 3.4% in Q3 2026, selling an estimated $811 and leaving 1,333 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2158.

Sterling Capital Management first reported a position in IART in Q3 2024 and has held it in 9 quarters since. The position peaked at $66.3K in Q3 2025. 115 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Sterling Capital Management held 1,333 shares of Integra LifeSciences worth $21.7K as of Q3 2026.
  • Sterling Capital Management sold 47 Integra LifeSciences shares in Q3 2026, an estimated $811.
  • Integra LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2158 holding.
  • Sterling Capital Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's Integra LifeSciences position peaked at $66.3K in Q3 2025.
  • 115 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.